What is Amoklavin Bid?
Amoklavin Bid is an antibiotic in a group of drugs called penicillins. Amoxicillin (Amoklavin Bid) fights bacteria in the body.
Clavulanate potassium is a form of Clavulanic Acid (Amoklavin Bid), which is similar to penicillin. Clavulanate potassium fights bacteria that is often resistant to penicillins and other antibiotics.
The combination of Amoxicillin (Amoklavin Bid) and clavulanate potassium is used to treat many different infections caused by bacteria, such as sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and infections of the skin.
Amoxicillin (Amoklavin Bid) and clavulanate potassium may also be used for purposes not listed in this medication guide.
AMOKLAVIN BID INDICATIONS
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains.
Amoklavin Bid-600 is indicated for the treatment of pediatric patients with recurrent or persistent acute otitis media due to S. pneumoniae (penicillin MICs ≤ 2 mcg/mL), H. influenzae (including β-lactamase–producing strains), or M. catarrhalis (including β-lactamase–producing strains) characterized by the following risk factors:
- antibiotic exposure for acute otitis media within the preceding 3 months, and either of the following:
- age ≤ 2 years
- daycare attendance
NOTE: Acute otitis media due to S. pneumoniae alone can be treated with Amoxicillin (Amoklavin Bid). Amoklavin Bid-600 is not indicated for the treatment of acute otitis media due to S. pneumoniae with penicillin MIC ≥ 4 mcg/mL.
Therapy may be instituted prior to obtaining the results from bacteriological studies when there is reason to believe the infection may involve both S. pneumoniae (penicillin MIC ≤ 2 mcg/mL) and the β-lactamase–producing organisms listed above.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Amoklavin Bid-600 and other antibacterial drugs, Amoklavin Bid-600 should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Each film-coated tablet contains Amoxicillin (Amoklavin Bid) trihydrate equivalent to Amoxicillin (Amoklavin Bid) 500 mg, and potassium clavulanate equivalent to Clavulanic Acid (Amoklavin Bid) 125 mg, respectively.
Each vial contains Amoxicillin (Amoklavin Bid) sodium equivalent to Amoxicillin (Amoklavin Bid) 1000 mg and clavulanate potassium equivalent to Clavulanic Acid (Amoklavin Bid) 200 mg, respectively.
Amoklavin Bid tablets also contains the following excipients: Microcrystalline cellulose, sodium starch glycolate, anhydrous colloidal silica, povidone (K30), eudragit E 100, isopropyl alcohol, magnesium stearate, white opadryl 03B58965, PEG400, methylene chloride.
Amoklavin Bid is an antibacterial combination consisting of the semi-synthetic antibiotic Amoxicillin (Amoklavin Bid) and the β-lactamase inhibitor, clavulanate potassium (the potassium salt of Clavulanic Acid (Amoklavin Bid)). Amoxicillin (Amoklavin Bid) is an analog of ampicillin, derived from the basic penicillin nucleus, 6-aminopenicillanic acid. Its molecular formula is C16H19N305S3H20 and the molecular weight is 419.46. Chemically, Amoxicillin (Amoklavin Bid) is (2S, 5R, 6R)-6-[(R)-(-)-2-Amino-2-(p-hydroxyphenyl) acetamido]-3, 3-dimethyl-7-oxo-4-1-azabicyclo[3.2.1] heptane-2-carboxylic acid trihydrate.
Amoxicillin (Amoklavin Bid): Clavulanic Acid (Amoklavin Bid) is produced by the fermentation of Streptomyces clavuligerus. It is a β-lactam structurally related to the penicillins and possesses the ability to inactivate a wide variety of β-lactamases by blocking the active sites of these enzymes. Clavulanic Acid (Amoklavin Bid) is particularly active against the clinically important plasmid-mediated β-lactamases frequently responsible for transferred drug resistance to penicillins and cephalosporins. The clavulanate potassium molecular formula is C8H8KN05 and the molecular weight is 237.25. Chemically, clavulanate potassium is potassium (Z)-(2R, 5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]-heptane-2-carboxylate. If a person is completely healthy, then he can get a good job, and find relevant vacancies on this site – https://jobstellar.com/uk/